Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.

Psychopharmacology bulletin

Volumn 40, Issue 3, 2007, Pages 15-28

  Robinson, Donald S ^a   Gilmor, Michelle L ^b   Yang, Ying ^b   Moonsammy, George ^b   Azzaro, Albert J ^b   Oren, Dan A ^b   Campbell, Bryan J ^b  

^a Worldwide Drug Development   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SELEGILINE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MAJOR DEPRESSION; MALE; META ANALYSIS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELEGILINE;

EID: 84862833507     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)